These data show that oral Salmonella-based vaccination breaks liver immunosuppression, thus favoring the development of a tumor-specific immune response in LDLN and, probably, the migration of effector CD8+IFN-γ+ T cells toward the liver. This evidence concerns the gene IFNG and neoplasm.